Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001199835-20-000136
Filing Date
2020-06-10
Accepted
2020-06-10 15:31:19
Documents
45
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 GENETHERA, INC. 10-K form-10k.htm 10-K 724563
2 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SAR ex31-1.htm EX-31.1 13720
3 CERTIFICATIONS OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECTION ex31-2.htm EX-31.2 13711
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB ex32-1.htm EX-32.1 6499
5 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECTION ex32-2.htm EX-32.2 6550
6 GRAPHIC gt001_v1.jpg GRAPHIC 10303
  Complete submission text file 0001199835-20-000136.txt   2218308

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE gnth-20191231.xml EX-101.INS 257080
8 XBRL SCHEMA FILE gnth-20191231.xsd EX-101.SCH 21108
9 XBRL CALCULATION FILE gnth-20191231_cal.xml EX-101.CAL 30279
10 XBRL DEFINITION FILE gnth-20191231_def.xml EX-101.DEF 64215
11 XBRL LABEL FILE gnth-20191231_lab.xml EX-101.LAB 152767
12 XBRL PRESENTATION FILE gnth-20191231_pre.xml EX-101.PRE 122868
Mailing Address 6860 BROADWAY UNIT B DENVER CO 80221
Business Address 6860 BROADWAY UNIT B DENVER CO 80221 3039550190
GENETHERA INC (Filer) CIK: 0001017110 (see all company filings)

EIN.: 650622463 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27237 | Film No.: 20954541
SIC: 2836 Biological Products, (No Diagnostic Substances)